FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 350:2140-2150 May 20, 2004 Number 21 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Perspective by Hlatky, M. A. Editorial by Rogers, J. G. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

ABSTRACT

Background We tested the hypothesis that prophylactic cardiac-resynchronization therapy in the form of biventricular stimulation with a pacemaker with or without a defibrillator would reduce the risk of death and hospitalization among patients with advanced chronic heart failure and intraventricular conduction delays.

Methods A total of 1520 patients who had advanced heart failure (New York Heart Association class III or IV) due to ischemic or nonischemic cardiomyopathies and a QRS interval of at least 120 msec were randomly assigned in a 1:2:2 ratio to receive optimal pharmacologic therapy (diuretics, angiotensin-converting–enzyme inhibitors, beta-blockers, and spironolactone) alone or in combination with cardiac-resynchronization therapy with either a pacemaker or a pacemaker–defibrillator. The primary composite end point was the time to death from or hospitalization for any cause.

Results As compared with optimal pharmacologic therapy alone, cardiac-resynchronization therapy with a pacemaker decreased the risk of the primary end point (hazard ratio, 0.81; P=0.014), as did cardiac-resynchronization therapy with a pacemaker–defibrillator (hazard ratio, 0.80; P=0.01). The risk of the combined end point of death from or hospitalization for heart failure was reduced by 34 percent in the pacemaker group (P<0.002) and by 40 percent in the pacemaker–defibrillator group (P<0.001 for the comparison with the pharmacologic-therapy group). A pacemaker reduced the risk of the secondary end point of death from any cause by 24 percent (P=0.059), and a pacemaker–defibrillator reduced the risk by 36 percent (P=0.003).

Conclusions In patients with advanced heart failure and a prolonged QRS interval, cardiac-resynchronization therapy decreases the combined risk of death from any cause or first hospitalization and, when combined with an implantable defibrillator, significantly reduces mortality.

Source Information

From the University of Colorado Health Sciences Center, Denver (M.R.B.); the University of Southern California, Los Angeles (L.A.S.); Milton S. Hershey Medical Center, Hershey, Pa. (J.B.); Bryan Memorial Hospital, Lincoln, Nebr. (S.K.); Johns Hopkins Hospital, Baltimore (D.A.K.); Moffit Hospital, University of California, San Francisco, San Francisco (T.D.M.); Washington, D.C., Veterans Affairs Medical Center, Washington, D.C. (P.C.); Pfizer Global Research and Development, Ann Arbor, Mich. (L.D.); University of Wisconsin–Madison Medical School, Madison (D. DeMets); Clinical Cardiovascular Research, Gaithersburg, Md. (B.G.W.); Guidant Corporation, St. Paul, Minn. (D. DeVries); and Jefferson Medical College, Philadelphia (A.M.F.).

Address reprint requests to Dr. Bristow at the Division of Cardiology, University of Colorado Health Sciences Center, 4200 E. Ninth Ave., Denver, CO 80262, or at michael.bristow{at}uchsc.edu.

Full Text of this Article

This article has been cited by other articles:

• Slaughter, M. S., Rogers, J. G., Milano, C. A., Russell, S. D., Conte, J. V., Feldman, D., Sun, B., Tatooles, A. J., Delgado, R. M. III, Long, J. W., Wozniak, T. C., Ghumman, W., Farrar, D. J., Frazier, O. H., the HeartMate II Investigators, (2009). Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device. NEJM 361: 2241-2251 [Abstract] [Full Text]  
• van Veldhuisen, D. J., Maass, A. H., Priori, S. G., Stolt, P., van Gelder, I. C., Dickstein, K., Swedberg, K. (2009). Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008. Eur J Heart Fail 11: 1143-1151 [Abstract] [Full Text]  
• Singh, J. P., Rosenthal, L. S., Hranitzky, P. M., Berg, K. C., Mullin, C. M., Thackeray, L., Kaplan, A. (2009). Device diagnostics and long-term clinical outcome in patients receiving cardiac resynchronization therapy. Europace 11: 1647-1653 [Abstract] [Full Text]  
• Suzuki, S., Furui, S., Yamakawa, T., Isshiki, T., Watanabe, A., Iino, R., Kidouchi, T., Nakano, Y. (2009). Radiation exposure to patients' skin during cardiac resynchronization therapy. Europace 11: 1683-1688 [Abstract] [Full Text]  
• Duray, G. Z., Hohnloser, S. H. (2009). Fighting with the invisible: radiation exposure in cardiac resynchronization therapy. Europace 11: 1575-1576 [Full Text]  
• Derval, N., Steendijk, P., Gula, L. J., Deplagne, A., Laborderie, J., Sacher, F., Knecht, S., Wright, M., Nault, I., Ploux, S., Ritter, P., Bordachar, P., Lafitte, S., Reant, P., Klein, G. J., Narayan, S. M., Garrigue, S., Hocini, M., Haissaguerre, M., Clementy, J., Jais, P. (2009). Optimizing Hemodynamics in Heart Failure Patients by Systematic Screening of Left Ventricular Pacing Sites: The Lateral Left Ventricular Wall and the Coronary Sinus Are Rarely the Best Sites. J Am Coll Cardiol 0: j.jacc.2009.08.045v1-15236 [Abstract] [Full Text]  
• Singh, J. P., Abraham, W. T. (2009). Enhancing the Response to Cardiac Resynchronization Therapy: Is It Time to Individualize the Left Ventricular Pacing Site?. J Am Coll Cardiol 0: j.jacc.2009.10.017v1-15258 [Full Text]  
• Mehta, P A, Dubrey, S W, McIntyre, H F, Walker, D M, Hardman, S M C, Sutton, G C, McDonagh, T A, Cowie, M. R (2009). Improving survival in the 6 months after diagnosis of heart failure in the past decade: population-based data from the UK. Heart 95: 1851-1856 [Abstract] [Full Text]  
• Kronborg, M. B., Nielsen, J. C., Mortensen, P. T. (2009). Electrocardiographic patterns and long-term clinical outcome in cardiac resynchronization therapy. Europace 0: eup364v1-eup364 [Abstract] [Full Text]  
• Daubert, C., Gold, M. R., Abraham, W. T., Ghio, S., Hassager, C., Goode, G., Szili-Torok, T., Linde, C., on behalf of the REVERSE Study Group, (2009). Prevention of Disease Progression by Cardiac Resynchronization Therapy in Patients With Asymptomatic or Mildly Symptomatic Left Ventricular Dysfunction: Insights From the European Cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) Trial. J Am Coll Cardiol 54: 1837-1846 [Abstract] [Full Text]  
• Exner, D. V. (2009). Is it Time to Expand the Use of Cardiac Resynchronization Therapy to Patients With Mildly Symptomatic Heart Failure?. J Am Coll Cardiol 54: 1847-1849 [Full Text]  
• St. John Sutton, M., Ghio, S., Plappert, T., Tavazzi, L., Scelsi, L., Daubert, C., Abraham, W. T., Gold, M. R., Hassager, C., Herre, J. M., Linde, C., on Behalf of the REsynchronization reVErses Remode, (2009). Cardiac Resynchronization Induces Major Structural and Functional Reverse Remodeling in Patients With New York Heart Association Class I/II Heart Failure. Circulation 120: 1858-1865 [Abstract] [Full Text]  
• Sassone, B., Gabrieli, L., Sacca, S., Boggian, G., Fusco, A., Pratola, C., Bacchi-Reggiani, M. L., Padeletti, L., Barold, S. S. (2009). Value of right ventricular-left ventricular interlead electrical delay to predict reverse remodelling in cardiac resynchronization therapy: the INTER-V pilot study. Europace 0: eup347v1-eup347 [Abstract] [Full Text]  
• Cabrera-Bueno, F., Fernandez-Pastor, J., Molina-Mora, M. J., Alzueta, J., Pena-Hernandez, J. L., Barrera, A., de Teresa-Galvan, E. (2009). Combined resynchronization therapy and automatic defibrillator in advanced non-ischaemic heart failure: the importance of QRS width. Europace 0: eup348v1-eup348 [Abstract] [Full Text]  
• Kamdar, R., Frain, E., Warburton, F., Richmond, L., Mullan, V., Berriman, T., Thomas, G., Tenkorang, J., Dhinoja, M., Earley, M., Sporton, S., Schilling, R. (2009). A prospective comparison of echocardiography and device algorithms for atrioventricular and interventricular interval optimization in cardiac resynchronization therapy. Europace 0: eup337v1-eup337 [Abstract] [Full Text]  
• Foley, P. W.X., Stegemann, B., Ng, K., Ramachandran, S., Proudler, A., Frenneaux, M. P., Ng, L. L., Leyva, F. (2009). Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy. Eur Heart J 30: 2749-2757 [Abstract] [Full Text]  
• Breithardt, G. (2009). MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy): cardiac resynchronization therapy towards early management of heart failure. Eur Heart J 30: 2551-2553 [Full Text]  
• Muellerleile, K., Baholli, L., Groth, M., Barmeyer, A. A., Koopmann, K., Ventura, R., Koester, R., Adam, G., Willems, S., Lund, G. K. (2009). Interventricular Mechanical Dyssynchrony: Quantification with Velocity-encoded MR Imaging. Radiology 253: 364-371 [Abstract] [Full Text]  
• Takahashi, A., Shiga, T., Shoda, M., Manaka, T., Ejima, K., Hagiwara, N. (2009). Impact of renal dysfunction on appropriate therapy in implantable cardioverter defibrillator patients with non-ischaemic dilated cardiomyopathy. Europace 11: 1476-1482 [Abstract] [Full Text]  
• Sciaraffia, E., Malmborg, H., Lonnerholm, S., Blomstrom, P., Blomstrom Lundqvist, C. (2009). Right ventricular contractility as a measure of optimal interventricular pacing setting in cardiac resynchronization therapy. Europace 11: 1496-1500 [Abstract] [Full Text]  
• Gasparini, M., Regoli, F., Galimberti, P., Ceriotti, C., Cappelleri, A. (2009). Cardiac resynchronization therapy in heart failure patients with atrial fibrillation. Europace 11: v82-v86 [Abstract] [Full Text]  
• Leclercq, C. (2009). Problems and troubleshooting in regular follow-up of patients with cardiac resynchronization therapy. Europace 11: v66-v71 [Abstract] [Full Text]  
• Sanaa, I., Franceschi, F., Prevot, S., Bastard, E., Deharo, J.-C. (2009). Is there a need for more than one left ventricular lead in some patients?. Europace 11: v29-v31 [Abstract] [Full Text]  
• Daubert, J. C., Leclercq, C., Mabo, P. (2009). Cardiac resynchronization therapy in combination with implantable cardioverter-defibrillator. Europace 11: v87-v92 [Abstract] [Full Text]  
• Foley, P. W.X., Leyva, F., Frenneaux, M. P. (2009). What is treatment success in cardiac resynchronization therapy?. Europace 11: v58-v65 [Abstract] [Full Text]  
• Miller, W. L., Hartman, K. A., Burritt, M. F., Grill, D. E., Jaffe, A. S. (2009). Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure.. J Am Coll Cardiol 54: 1715-1721 [Abstract] [Full Text]  
• van Bommel, R. J., Bax, J. J., Abraham, W. T., Chung, E. S., Pires, L. A., Tavazzi, L., Zimetbaum, P. J., Gerritse, B., Kristiansen, N., Ghio, S. (2009). Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis. Eur Heart J 30: 2470-2477 [Abstract] [Full Text]  
• Dickstein, K., Bogale, N., Priori, S., Auricchio, A., Cleland, J. G., Gitt, A., Limbourg, T., Linde, C., van Veldhuisen, D. J., Brugada, J., on behalf of the Scientific Committee and National, (2009). The European cardiac resynchronization therapy survey. Eur Heart J 30: 2450-2460 [Abstract] [Full Text]  
• Steffel, J., Hurlimann, D. (2009). Current practice of cardiac resynchronization therapy (CRT) in the real world: insights from the European CRT survey. Eur Heart J 30: 2433-2435 [Full Text]  
• Borleffs, C. J. W., Scherptong, R. W.C., Man, S.-C., van Welsenes, G. H., Bax, J. J., van Erven, L., Swenne, C. A., Schalij, M. J. (2009). Predicting Ventricular Arrhythmias in Patients With Ischemic Heart Disease: Clinical Application of the ECG-Derived QRS-T Angle. Circ Arrhythm Electrophysiol 2: 548-554 [Abstract] [Full Text]  
• Moss, A. J., Hall, W. J., Cannom, D. S., Klein, H., Brown, M. W., Daubert, J. P., Estes, N.A. M. III, Foster, E., Greenberg, H., Higgins, S. L., Pfeffer, M. A., Solomon, S. D., Wilber, D., Zareba, W., the MADIT-CRT Trial Investigators, (2009). Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events. NEJM 361: 1329-1338 [Abstract] [Full Text]  
• Leyva, F, Foley, P W X, Stegemann, B, Ward, J A, Ng, L L, Frenneaux, M P, Regoli, F, Smith, R E A, Auricchio, A (2009). Development and validation of a clinical index to predict survival after cardiac resynchronisation therapy. Heart 95: 1619-1625 [Abstract] [Full Text]  
• Patwala, A., Woods, P., Clements, R., Albouaini, K., Rao, A., Goldspink, D., Tan, L.-B., Oo, A., Wright, D. (2009). A prospective longitudinal evaluation of the benefits of epicardial lead placement for cardiac resynchronization therapy. Europace 11: 1323-1329 [Abstract] [Full Text]  
• Bonakdar, H. R., Jorat, M. V., Fazelifar, A. F., Alizadeh, A., Givtaj, N., Sameie, N., Sadeghpour, A., Haghjoo, M. (2009). Prediction of response to cardiac resynchronization therapy using simple electrocardiographic and echocardiographic tools. Europace 11: 1330-1337 [Abstract] [Full Text]  
• Boriani, G., Gasparini, M., Landolina, M., Lunati, M., Biffi, M., Santini, M., Padeletti, L., Molon, G., Botto, G., De Santo, T., Valsecchi, S., on behalf of the InSync/InSync ICD Italian Registr, (2009). Effectiveness of cardiac resynchronization therapy in heart failure patients with valvular heart disease: comparison with patients affected by ischaemic heart disease or dilated cardiomyopathy. The InSync/InSync ICD Italian Registry. Eur Heart J 30: 2275-2283 [Abstract] [Full Text]  
• Berger, R., Shankar, A., Fruhwald, F., Fahrleitner-Pammer, A., Freemantle, N., Tavazzi, L., Cleland, J. G.F., Pacher, R. (2009). Relationships between cardiac resynchronization therapy and N-terminal pro-brain natriuretic peptide in patients with heart failure and markers of cardiac dyssynchrony: an analysis from the Cardiac Resynchronization in Heart Failure (CARE-HF) study. Eur Heart J 30: 2109-2116 [Abstract] [Full Text]  
• Stahlberg, M., Damgaard, M., Norsk, P., Gabrielsen, A., Sahlen, A., Linde, C., Braunschweig, F. (2009). Cardiac output response to changes of the atrioventricular delay in different body positions and during exercise in patients receiving cardiac resynchronization therapy. Europace 11: 1160-1167 [Abstract] [Full Text]  
• Brignole, M. (2009). Are complications of implantable defibrillators under-estimated and benefits over-estimated?. Europace 11: 1129-1133 [Full Text]  
• Kronborg, M. B., Albertsen, A. E., Nielsen, J. C., Mortensen, P. T. (2009). Long-term clinical outcome and left ventricular lead position in cardiac resynchronization therapy. Europace 11: 1177-1182 [Abstract] [Full Text]  
• Diamond, G. A., Kaul, S. (2009). Bayesian Classification of Clinical Practice Guidelines. Arch Intern Med 169: 1431-1435 [Abstract] [Full Text]  
• Hsich, E. M., Pina, I. L. (2009). Heart failure in women: a need for prospective data.. J Am Coll Cardiol 54: 491-498 [Abstract] [Full Text]  
• Biffi, M., Moschini, C., Bertini, M., Saporito, D., Ziacchi, M., Diemberger, I., Valzania, C., Domenichini, G., Cervi, E., Martignani, C., Sangiorgi, D., Branzi, A., Boriani, G. (2009). Phrenic Stimulation: A Challenge for Cardiac Resynchronization Therapy. Circ Arrhythm Electrophysiol 2: 402-410 [Abstract] [Full Text]  
• Barth, A. S., Aiba, T., Halperin, V., DiSilvestre, D., Chakir, K., Colantuoni, C., Tunin, R. S., Dimaano, V. L., Yu, W., Abraham, T. P., Kass, D. A., Tomaselli, G. F. (2009). Cardiac Resynchronization Therapy Corrects Dyssynchrony-Induced Regional Gene Expression Changes on a Genomic Level. Circ Cardiovasc Genet 2: 371-378 [Abstract] [Full Text]  
• Israel, C. W. (2009). Do some implant too many defibrillators or others too few?. Europace 11: 982-984 [Full Text]  
• Task force members, , Vijgen, J., Botto, G., Camm, J., Hoijer, C.-J., Jung, W., Le Heuzey, J.-Y., Lubinski, A., Norekval, T. M., Santomauro, M., Schalij, M., Schmid, J.-P., Vardas, P. (2009). Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators. Europace 11: 1097-1107 [Abstract] [Full Text]  
• Schmidt, M., Rittger, H., Marschang, H., Sinha, A.-M., Daccarett, M., Brachmann, J., Block, M., Breithardt, O. A. (2009). Left ventricular dyssynchrony from right ventricular pacing depends on intraventricular conduction pattern in intrinsic rhythm. Eur J Echocardiogr 10: 776-783 [Abstract] [Full Text]  
• Schofer, J., Siminiak, T., Haude, M., Herrman, J. P., Vainer, J., Wu, J. C., Levy, W. C., Mauri, L., Feldman, T., Kwong, R. Y., Kaye, D. M., Duffy, S. J., Tubler, T., Degen, H., Brandt, M. C., Van Bibber, R., Goldberg, S., Reuter, D. G., Hoppe, U. C. (2009). Percutaneous Mitral Annuloplasty for Functional Mitral Regurgitation: Results of the CARILLON Mitral Annuloplasty Device European Union Study. Circulation 120: 326-333 [Abstract] [Full Text]  
• Janousek, J, Gebauer, R A, Abdul-Khaliq, H, Turner, M, Kornyei, L, Grollmuss, O, Rosenthal, E, Villain, E, Fruh, A, Paul, T, Blom, N A, Happonen, J-M, Bauersfeld, U, Jacobsen, J R, van den Heuvel, F, Delhaas, T, Papagiannis, J, Trigo, C, for the Working Group for Cardiac Dysrhythmias and, (2009). Cardiac resynchronisation therapy in paediatric and congenital heart disease: differential effects in various anatomical and functional substrates. Heart 95: 1165-1171 [Abstract] [Full Text]  
• Baliga, V., Sapsford, R. (2009). Review article: Diabetes mellitus and heart failure -- an overview of epidemiology and management. Diabetes and Vascular Disease Research 6: 164-171 [Abstract]  
• Mont, L., Guasch, E., Berruezo, A. (2009). An implantable defibrillator and what else?. Eur Heart J 30: 1551-1553 [Full Text]  
• Gervais, R., Leclercq, C., Shankar, A., Jacobs, S., Eiskjaer, H., Johannessen, A., Freemantle, N., Cleland, J. G.F., Tavazzi, L., Daubert, C., on behalf of the CARE-HF investigators, (2009). Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub-analysis of the CARE-HF trial. Eur J Heart Fail 11: 699-705 [Abstract] [Full Text]  
• Zhang, Q, van Bommel, R J, Fung, J W-H, Chan, J Y-S, Bleeker, G B, Ypenburg, C, Yip, G, Liang, Y-j, Schalij, M J, Bax, J J, Yu, C-M (2009). Tissue Doppler velocity is superior to strain imaging in predicting long-term cardiovascular events after cardiac resynchronisation therapy. Heart 95: 1085-1090 [Abstract] [Full Text]  
• Patwala, A. Y., Woods, P. R., Sharp, L., Goldspink, D. F., Tan, L. B., Wright, D. J. (2009). Maximizing Patient Benefit From Cardiac Resynchronization Therapy With the Addition of Structured Exercise Training: A Randomized Controlled Study. J Am Coll Cardiol 53: 2332-2339 [Abstract] [Full Text]  
• Eberhardt, F., Heringlake, M., Massalme, M. S., Dyllus, A., Misfeld, M., Sievers, H.-H., Wiegand, U. K.H., Hanke, T. (2009). The effect of biventricular pacing after coronary artery bypass grafting: A prospective randomized trial of different pacing modes in patients with reduced left ventricular function.. J. Thorac. Cardiovasc. Surg. 137: 1461-1467 [Abstract] [Full Text]  
• Agricola, E., Ielasi, A., Oppizzi, M., Faggiano, P., Ferri, L., Calabrese, A., Vizzardi, E., Alfieri, O., Margonato, A. (2009). Long-term prognosis of medically treated patients with functional mitral regurgitation and left ventricular dysfunction. Eur J Heart Fail 11: 581-587 [Abstract] [Full Text]  
• Dilaveris, P., Giannopoulos, G., Synetos, A., Aggeli, C., Raftopoulos, L., Arsenos, P., Gatzoulis, K., Stefanadis, C. (2009). Effect of biventricular pacing on ventricular repolarization and functional indices in patients with heart failure: lack of association with arrhythmic events. Europace 11: 741-750 [Abstract] [Full Text]  
• Bax, J. J., Gorcsan, J. III (2009). Echocardiography and noninvasive imaging in cardiac resynchronization therapy: results of the PROSPECT (Predictors of Response to Cardiac Resynchronization Therapy) study in perspective.. J Am Coll Cardiol 53: 1933-1943 [Full Text]  
• Hawkins, N. M., Petrie, M. C., Burgess, M. I., McMurray, J. J.V. (2009). Selecting patients for cardiac resynchronization therapy: the fallacy of echocardiographic dyssynchrony.. J Am Coll Cardiol 53: 1944-1959 [Abstract] [Full Text]  
• Boveda, S., Marijon, E., Jacob, S., Defaye, P., Winter, J. B., Bulava, A., Gras, D., Albenque, J. P., Combes, N., Pavin, D., Delarche, N., Teubl, A., Lambiez, M., Chevalier, P., on behalf of the Mona Lisa Study Group, (2009). Incidence and prognostic significance of sustained ventricular tachycardias in heart failure patients implanted with biventricular pacemakers without a back-up defibrillator: results from the prospective, multicentre, Mona Lisa cohort study. Eur Heart J 30: 1237-1244 [Abstract] [Full Text]  
• Boogers, M. M., Van Kriekinge, S. D., Henneman, M. M., Ypenburg, C., Van Bommel, R. J., Boersma, E., Dibbets-Schneider, P., Stokkel, M. P., Schalij, M. J., Berman, D. S., Germano, G., Bax, J. J. (2009). Quantitative Gated SPECT-Derived Phase Analysis on Gated Myocardial Perfusion SPECT Detects Left Ventricular Dyssynchrony and Predicts Response to Cardiac Resynchronization Therapy. JNM 50: 718-725 [Abstract] [Full Text]  
• Borleffs, C. J. W., van Bommel, R. J., Molhoek, S. G., de Leeuw, J. G., Schalij, M. J., van Erven, L. (2009). Requirement for coronary sinus lead interventions and effectiveness of endovascular replacement during long-term follow-up after implantation of a resynchronization device. Europace 11: 607-611 [Abstract] [Full Text]  
• Tomlinson, D. R., Bashir, Y., Betts, T. R., Rajappan, K. (2009). Accuracy of manual QRS duration assessment: its importance in patient selection for cardiac resynchronization and implantable cardioverter defibrillator therapy. Europace 11: 638-642 [Abstract] [Full Text]  
• Alonso, C. (2009). In the field of cardiac resynchronization therapy is left ventricular pacing via the coronary sinus a mature technique. Europace 11: 544-545 [Full Text]  
• Khan, F. Z., Virdee, M. S., Fynn, S. P., Dutka, D. P. (2009). Left ventricular lead placement in cardiac resynchronization therapy: where and how?. Europace 11: 554-561 [Abstract] [Full Text]  
• Cubbon, R. M, Witte, K. K A (2009). Cardiac resynchronisation therapy for chronic heart failure and conduction delay. BMJ 338: b1265-b1265 [Full Text]  
• Curtis, J. P., Luebbert, J. J., Wang, Y., Rathore, S. S., Chen, J., Heidenreich, P. A., Hammill, S. C., Lampert, R. I., Krumholz, H. M. (2009). Association of Physician Certification and Outcomes Among Patients Receiving an Implantable Cardioverter-Defibrillator. JAMA 301: 1661-1670 [Abstract] [Full Text]  
• Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 53: e1-e90 [Full Text]  
• Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 53: 1343-1382 [Full Text]  
• 2009 WRITING GROUP TO REVIEW NEW EVIDENCE AND UPDA, , Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation 119: 1977-2016 [Full Text]  
• 2005 WRITING COMMITTEE MEMBERS, , Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation 119: e391-e479 [Full Text]